Page 131 - OR-1-3
P. 131

for tendon organoids. Appropriate mechanical stimuli   organoids and drive the field toward greater refinement
            can induce cells to differentiate into tenocyte phenotypes,   (Figure 2).
            which is crucial for the maturation and functionalization of
            tendon organoids.                                 4.4.1. Optimizing materials for omics and gene editing
                                                              technologies
               Future organoid platforms should aim to model
            both  fibrotic  and  healthy  tendon  microenvironments,   The optimization of cell sources, scaffolds, and biochemical
            enabling interventions to disrupt degenerative cycles   factors  is  critical  for  enhancing  the  functionality  and
            while  promoting  physiological  collagen  remodeling.  This   biomimicry of organoids. Single-cell RNA sequencing
            approach allows stage-specific customization of therapies   (RNA-seq) technology can resolve the heterogeneity of
            tailored to the progression of tendon degeneration. To   stem cell populations, 32,33  identifying the most suitable
            fibrosis-specific organoids, although resembling native   stem cell subpopulations for tendon differentiation as seed
            fibril morphology, their disordered collagen cross-linking   cells for tendon organoid construction. Single-cell analysis
            results in compromised mechanical properties. Such   can characterize the gene expression profiles of individual
            models can evaluate fibrosis-associated molecular events   cells isolated from tendon tissue, revealing subpopulations
                                                                                                      33
                                                                     +
            or test therapeutic strategies. By comparing responses   of nestin  TSPCs with strong tenogenic potential,  which
            between healthy and fibrotic organoids—such as collagen   can be utilized for tendon organoid development. Studies
            reorganization efficiency under  mechanical  loading—  using  RNA-seq  have  demonstrated  that  changes  in  the
            critical thresholds in pathological progression can be   microenvironment during 3D culture of human TSPCs
            identified, offering precise targets for clinically reversing   affect the proportions of different cell subpopulations,
                                                                                           66
            fibrosis.  By optimizing  the mechanical  environment,  the   thereby regulating stem cell function.  Analyzing epigenetic
            physical properties  of the  ECM, the  selection  of scaffold   modifications in stem cells, such as DNA methylation
            materials, and the application of biomechanical stimuli, it   and histone  modifications,  can reveal key  epigenetic
            is possible to replicate the physiological and pathological   mechanisms governing tendon differentiation, optimizing
            processes of tendons, promoting the formation and   the directed differentiation of stem cells. By examining
            functionalization of tendon organoids. However, the   gene expression profiles under different biochemical
            widespread  implementation  of  these  approaches  faces   treatments, the most effective combinations of small
            significant challenges. A major limitation lies in the lack   molecules for promoting tendon differentiation can be
            of standardized engineering platforms tailored for tendon   identified. Similarly, analyzing protein expression profiles
            organoid culture, which require seamless integration   on scaffold surfaces can help select materials that enhance
            of scaffold customization and dynamic loading of   cell adhesion, proliferation, and differentiation. 145,146  For
            biomechanics.  Current systems often depend on bulky   example, proteomic studies have demonstrated that lower
                        140
            bioreactors or 2D stretching devices that fail to recapitulate   material stiffness promotes tenogenic differentiation in
            the  3D  multiaxial  mechanical  cues  (e.g.,  tension,  shear,   stem cells, providing evidence for optimizing the design
                                                                                                       146
            and compression) experienced by tendons  in vivo. 141-143    of bioactive scaffolds in tendon tissue engineering.  The
            Moreover, scalable and user-friendly technologies for   application of novel genome editing technologies and
            applying spatially resolved mechanical stimuli within   high-throughput screening methods further supports the
            high-throughput organoid arrays are still underdeveloped,   optimization of stem cell culture conditions.
            hindering systematic exploration of mechanobiological   Organ-on-a-chip  technology  is  a  biomimetic
            responses.  Future research should further explore the   platform based on microfluidics that can simulate the
                     144
            synergistic mechanisms of these physical factors while   microenvironment of human tissues, 61,62  offering a novel tool
            addressing these engineering challenges, providing more   for the construction and investigation of tendon organoids.
            comprehensive theoretical and technical support for the   By integrating cells, scaffold materials, and mechanical stimuli
            construction of tendon organoids.                 into a microchip, this technology precisely regulates the
                                                              microenvironment of tendon organoids, enabling dynamic
            4.4. Engineering strategies                       research on their development, function, and pathological
            As outlined above, the construction of tendon organoids   processes. Leveraging microfluidic technology, this platform
            involves the multidimensional synergy of cells, materials,   facilitates accurate drug delivery and mimics in vivo fluid
            mechanical environments, and biochemical signals.   transport, while also applying dynamic stretching or
            Advanced engineering technologies enable precise   shear  forces to replicate the mechanical  environment
            design and optimization from the molecular level to the   of tendons within the body. This approach accurately
            macroscopic scale. Through interdisciplinary collaboration   simulates the biochemical and physical conditions of actual
            and technological innovation, engineering strategies   organs, supporting high-throughput screening and drug
            provide the technical foundation for constructing tendon   testing. 147-149  In addition, organ-on-a-chip technology can



            Volume 1 Issue 3 (2025)                         11                           doi: 10.36922/OR025170016
   126   127   128   129   130   131   132   133   134   135   136